These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SUMO proteins in the cardiovascular system: friend or foe? Shetty PMV; Rangrez AY; Frey N J Biomed Sci; 2020 Oct; 27(1):98. PubMed ID: 33099299 [TBL] [Abstract][Full Text] [Related]
3. Coordination of Cellular Localization-Dependent Effects of Sumoylation in Regulating Cardiovascular and Neurological Diseases. Abe JI; Sandhu UG; Hoang NM; Thangam M; Quintana-Quezada RA; Fujiwara K; Le NT Adv Exp Med Biol; 2017; 963():337-358. PubMed ID: 28197922 [TBL] [Abstract][Full Text] [Related]
4. SUMO: From Bench to Bedside. Chang HM; Yeh ETH Physiol Rev; 2020 Oct; 100(4):1599-1619. PubMed ID: 32666886 [TBL] [Abstract][Full Text] [Related]
5. Potential Role of SUMO and SUMOylation in the Pathogenesis of Diabetes Mellitus. Sadeghi M; Dehnavi S; Shohan M; Jamialahmadi T; Sathyapalan T; Sahebkar A Curr Med Chem; 2023; 30(14):1623-1637. PubMed ID: 35980066 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms, regulation and consequences of protein SUMOylation. Wilkinson KA; Henley JM Biochem J; 2010 May; 428(2):133-45. PubMed ID: 20462400 [TBL] [Abstract][Full Text] [Related]
7. The post-translational modification, SUMOylation, and cancer (Review). Han ZJ; Feng YH; Gu BH; Li YM; Chen H Int J Oncol; 2018 Apr; 52(4):1081-1094. PubMed ID: 29484374 [TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases. Hua D; Wu X Eur J Med Chem; 2022 Apr; 233():114227. PubMed ID: 35247754 [TBL] [Abstract][Full Text] [Related]
9. Targeting SUMOylation cascade for diabetes management. Sireesh D; Bhakkiyalakshmi E; Ramkumar KM; Rathinakumar S; Jennifer PS; Rajaguru P; Paulmurugan R Curr Drug Targets; 2014; 15(12):1094-106. PubMed ID: 25230117 [TBL] [Abstract][Full Text] [Related]
10. De-SUMOylation enzyme of sentrin/SUMO-specific protease 2 regulates disturbed flow-induced SUMOylation of ERK5 and p53 that leads to endothelial dysfunction and atherosclerosis. Heo KS; Chang E; Le NT; Cushman H; Yeh ET; Fujiwara K; Abe J Circ Res; 2013 Mar; 112(6):911-23. PubMed ID: 23381569 [TBL] [Abstract][Full Text] [Related]
11. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation. Chen S; Dong D; Xin W; Zhou H Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931 [TBL] [Abstract][Full Text] [Related]
12. Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates? Cheng X; Yang W; Lin W; Mei F Pharmacol Rev; 2023 Sep; 75(5):979-1006. PubMed ID: 37137717 [TBL] [Abstract][Full Text] [Related]
13. Roles for SUMO modification during senescence. Andreou AM; Tavernarakis N Adv Exp Med Biol; 2010; 694():160-71. PubMed ID: 20886763 [TBL] [Abstract][Full Text] [Related]
14. SUMOylation in atherosclerosis. Liu YZ; Xiao X; Hu CT; Dai Y; Qu SL; Huang L; Zhang C Clin Chim Acta; 2020 Sep; 508():228-233. PubMed ID: 32439557 [TBL] [Abstract][Full Text] [Related]
15. Protein SUMOylation in neuropathological conditions. Anderson DB; Wilkinson KA; Henley JM Drug News Perspect; 2009 Jun; 22(5):255-65. PubMed ID: 19609463 [TBL] [Abstract][Full Text] [Related]
16. [Advances on SUMO substrates in Arabidopsis]. Guo MX; Fu YF Yi Chuan; 2013 Jun; 35(6):727-34. PubMed ID: 23774017 [TBL] [Abstract][Full Text] [Related]
17. The function of SUMOylation and its crucial roles in the development of neurological diseases. Chen X; Zhang Y; Wang Q; Qin Y; Yang X; Xing Z; Shen Y; Wu H; Qi Y FASEB J; 2021 Apr; 35(4):e21510. PubMed ID: 33710677 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the SUMOylation pathway in Drosophila. Talamillo A; Sánchez J; Barrio R Biochem Soc Trans; 2008 Oct; 36(Pt 5):868-73. PubMed ID: 18793153 [TBL] [Abstract][Full Text] [Related]
19. Deciphering the SUMO code in the kidney. Yang Z; Zhang Y; Sun S J Cell Mol Med; 2019 Feb; 23(2):711-719. PubMed ID: 30506859 [TBL] [Abstract][Full Text] [Related]
20. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy. Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]